Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Swiss army knife for the treatment of bone cancers: a new multifunctional platform based upon SPIONs@copper-doped bioactive glass core-shell nanoparticles.

Nanoscale·2026
Same author

Impact of volcanic emissions on the air quality during the 2021 volcanic eruption of Tajogaite, La Palma: Implications for population exposure to volcanic pollutants.

The Science of the total environment·2026
Same author

Submarine ash megabed fed by far-traveled, shoreline-crossing pyroclastic currents from a large explosive volcanic eruption.

Science advances·2025
Same author

Triggered by light and magnetism: smart foam PLLA/HAP/Fe<sub>3</sub>O<sub>4</sub> scaffolds for heat-controlled biomedical applications.

Journal of materials chemistry. B·2025
Same author

Novel Honeycomb Nanoclay Frameworks With Hemostatic and Antibacterial Properties.

Journal of biomedical materials research. Part B, Applied biomaterials·2024
Same author

Correlating the Effect of Composition and Textural Properties on Bioactivity for Pristine and Copper-Doped Binary Mesoporous Bioactive Glass Nanoparticles.

Materials (Basel, Switzerland)·2023

Related Experiment Video

Updated: Oct 27, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.0K

Tranexamic acid-loaded hemostatic nanoclay microsphere frameworks.

Isabelle Denry1,2,3, Jean-Marie Nédélec3, Julie A Holloway2

  • 1Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, Iowa, USA.

Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|July 21, 2021
PubMed
Summary

Newly developed nanoclay microsphere frameworks loaded with tranexamic acid enhance hemostasis. These novel hemostatic agents improve clot structure and stiffness, offering potential for advanced hemorrhage control.

Keywords:
clotting timehemostasisnanoclaytopical hemostatic agenttranexamic acid

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.4K
Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 27, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.0K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.4K
Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.4K

Area of Science:

  • Biomaterials Science
  • Hemostasis and Thrombosis Research
  • Nanotechnology Applications

Background:

  • Effective hemorrhage control relies on fast-acting topical hemostatic agents.
  • Retarding fibrinolysis is crucial for enhancing coagulation and improving survival rates.

Purpose of the Study:

  • To investigate the physical properties, loading capacity, and hemostatic efficacy of novel nanoclay microsphere frameworks (NMFs).
  • To evaluate NMFs loaded with tranexamic acid (TA) as an antifibrinolytic agent for improved hemostasis.

Main Methods:

  • Preparation of nanoclay compositions with varying levels of tranexamic acid (TA).
  • Assessment of TA incorporation and release from the nanoclay structure.
  • Evaluation of hemostatic properties, including activated partial thromboplastin time and clot stiffness.

Main Results:

  • Successful incorporation and ethanol-induced release of TA from the nanoclay structure.
  • Both TA-loaded and undoped NMFs significantly reduced activated partial thromboplastin time.
  • NMFs demonstrated increased clot stiffness, attributed to thinner fibrin fibers and denser clot structure.

Conclusions:

  • Newly developed nanoclay microsphere frameworks effectively incorporate and release tranexamic acid.
  • NMFs show significant potential as topical hemostatic agents by enhancing clot structure and reducing fibrinolysis.